Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Persistent posttraumatic headache risk factors confirmed

Publish date:: June 17, 2020

Key clinical point: The findings could inform patient management to reduce progression to persistent headache.

Major finding: Heightened risk was associated with migraine history (relative risk, 2.4), previous head injury (odds ratio, 5.8), medication overuse (RR, 2.6) and psychological history (OR, 5).

Study details: A retrospective analysis of 300 patients.

Disclosures: The study did not receive any funding. Dr. Chan had no relevant financial disclosures. Dr. Charles consults for consults for Amgen, BioHaven, Eli Lilly, Novartis, and Lundbeck.

Citation:

Chan T et al. AHS 2020.

This Week's Must Reads

COVID-19 vaccine found effective but doctors watching for reactions, adverse events,

Study links sleep meds and dementia risk in older adults,

Childhood Hodgkin survivors have neurocognitive impairment,

Obesity, hypoxia predict severity in children with COVID-19,

Long-term safety and efficacy of teriflunomide for relapsing MS,

Must Reads in Headache & Migraine

HIT-6 may help track meaningful change in chronic migraine,

Choroid plexuses may play a role in migraine,

Multiple traits more common in difficult-to-treat patients with migraine,

Marijuana for migraine? Some tentative evidence,

Low vitamin D levels in patients with migraine,